您的位置: 首页 > 农业专利 > 详情页

(2S)-N-[(1S)-1-ciano-2-feniletil]-1,4-oxazepán-2-karboxamidok, mint dipeptidil peptidáz I gátlók
专利权人:
Astrazeneca AB
发明人:
LOENN, Hans,CONNOLLY, Stephen,SWALLOW, Steven,KARLSSON, Staffan PO,AURELL, Carl-Johan,PONTEN, John Fritiof,DOYLE, Kevin,VAN DE POËL, Amanda,JONES, Graham,WATSON, David,MACRITCHIE, Jaqueline,PALMER, Ni
申请号:
HUE15701577
公开号:
HUE038274T2
申请日:
2015.01.23
申请国别(地区):
HU
年份:
2018
代理人:
摘要:
The present disclosure relates to certain (2 S )- N -[(1 S )-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充